Editorial: Redox-signaling in neurodegenerative diseases: biomarkers, targets, and therapies

Andreia N Carvalho; Vasco Branco; Jack van Horssen; Luciano Saso

doi:10.3389/fncel.2023.1198669

Editorial: Redox-signaling in neurodegenerative diseases: biomarkers, targets, and therapies

Front Cell Neurosci. 2023 Apr 20:17:1198669. doi: 10.3389/fncel.2023.1198669. eCollection 2023.

Authors

Andreia N Carvalho¹, Vasco Branco^{1

2}, Jack van Horssen³, Luciano Saso⁴

Affiliations

¹ Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, Lisbon, Portugal.
² Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, Caparica, Portugal.
³ Department of Molecular Cell Biology and Immunology, MS Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam Neurosciences, Amsterdam UMC Location VUmc, Amsterdam, Netherlands.
⁴ Department of Physiology and Pharmacology, Faculty of Pharmacy and Medicine, Sapienza University of Rome, Rome, Italy.

No abstract available

Keywords: Nrf2; antioxidants; neurodegenerative diseases; oxidative stress; post-translational modifications (PTMs); redox-signaling.

Publication types

Editorial

Grants and funding

This work was supported in part by national funds from Fundação para a Ciência e Tecnologia (FCT), Portugal through Norma Transitória – DL57/2016 and grant EXPL/BIA-BQM/0793/2021 (to AC) and Norma Transitória – DL57/2016/CP1376/CT002 (to VB).